Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Parsippany, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Melinta Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Melinta Therapeutics Inc market cap is $1.51M.
What is the 52-week high for Melinta Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Melinta Therapeutics Inc 52 week high is $8.60 as of September 16, 2025.
What is the 52-week low for Melinta Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Melinta Therapeutics Inc 52 week low is $0.06 as of September 16, 2025.
What was Melinta Therapeutics Inc stock price yesterday?
Melinta Therapeutics Inc stock price yesterday was $0.11.
What is the PE ratio of Melinta Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Melinta Therapeutics Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Melinta Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Melinta Therapeutics Inc P/B ratio is -0.0250.
What is the 50-day moving average of Melinta Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Melinta Therapeutics Inc 50-day moving average is $0.1458.